drugset / Trial / NCT04836819

Analgesia Management in Bariatric Surgery

NCT04836819 ↗

Completed 78 enrolled Ondokuz Mayıs University
RandomizedParallel-groupDouble-blindSupportive care

Summary

Following laparoscopic bariatric surgery, multimodal analgesia is recommended to avoid the adverse effects of opioids by reducing their use. Although lidocaine, ketamine, and dexmedetomidine have been used as adjuvant analgesics, no studies have evaluated the superiority of their intra- and postoperative infusions as components of multimodal analgesia in bariatric surgery. The present study is aimed to compare lidocaine, dexmedetomidine, and ketamine in multimodal analgesia management following Sleeve Gastrectomy Surgery. Postoperative pain scores, the requirement for additional postoperative analgesia, retching, nausea and vomiting, time to mobilization, and hospital length of stay will be evaluated.

Timeline

Start
2021-04-08
Primary completion
2021-06-05
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.3 mg/kg Intravenous
Comparator Ketamine Small molecule 0.3 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 1 mg/kg Intravenous

Indications